The potential absorptive role of the yolk sac membrane was evaluated by examining protein and enzyme patterns in embryonic fluids and by comparing the synthetic capacity of the secondary yolk sac, fetal liver and placenta for human chorionic gonadotrophin (HCG) and α-fetoprotein (αFP). In yolk sac fluid samples, protein electrophoresis showed two main electrophoretic bands with mobilities comparable to those of albumin and interalbumin-α1-globulin, and immunoblotting revealed the presence of albumin, αFP, α1-antitrypsin, α2-macroglobulin, transferrin, complement factors 3 and 4 and immunoglobulin G. In coelomic fluid, similar results were obtained, except for the absence of α2-macroglobulin and the presence of ceruloplasmin and IgA. After electrophoresis and immunoblotting with specific antibodies, β-HCG was detected in all placental homogenates and culture media but was not revealed in any of the corresponding yolk sac tissue samples. Reverse transcription-polymerase chain reaction (RT-PCR) showed that all placental samples express β-HCG mRNA whereas all yolk sac and liver samples express αFP mRNA. These findings suggest that the yolk sac membrane is an important zone of transfer between the extra-embryonic and embryonic compartments and may also help to further develop therapeutic protocols making use of fetal somatic gene therapy by injecting transduced cells into the exocoelomic cavity.
Introduction
The yolk sac plays a major role in the embryonic development of all mammals. The function of the yolk sac has been most extensively studied in laboratory rodents and it has been demonstrated that the extra-embryonic yolk sac is one of the initial sites of haematopoiesis (Medvinsky et al., 1993) . The rodent visceral yolk sac envelops the gestational sac and serves as the principal membrane for materno-fetal exchanges throughout pregnancy (Thomas et al., 1990) . It is also capable of protein synthesis and proteins are secreted into both embryonic and extra-embryonic compartments and is often used as a model for experimental embryology and reproductive toxicology (Dunton et al., 1986; Brent et al., 1990) .
The human secondary yolk sac is an independent organ floating in the exocoelomic cavity (ECC) between the placenta and the amniotic cavity containing the developing embryo ( Figure 1 ). From the 6th week of gestation it appears as a spherical and cystic structure covered by numerous superficial small vessels merging at the basis of the vitelline duct which connects the yolk sac to the ventral part of the embryo to its gut, and to its main blood circulation (Gonzales-Crussi and Roth, 1976; Jones and Jauniaux, 1995) . The extra-embryonic human circulation is first established within the vitelline duct artery via the dorsal aorta. During the 10th week of gestation the yolk sac starts to degenerate and becomes rapidly nonfunctional (Jones and Jauniaux, 1995) . During its transitory life, it has a demonstrated role in haematopoiesis (Migliaccio et al., 1986) and protein biosynthesis (Gitlin and Perricelli, 1970; Shi et al., 1985) , until the embryonic liver has matured sufficiently to carry out these functions.
The wall of the secondary yolk sac is formed by an external mesothelial layer facing the ECC, a vascular mesenchyme and an endodermal layer facing the yolk sac cavity (GonzalesCrussi and Roth, 1976; Jones and Jauniaux, 1995) . Previous in-vitro studies have demonstrated that the yolk sac endodermal layer is the source of several proteins including pre-albumin, albumin, α-fetoprotein (αFP), α1-antitrypsin and transferrin (Gitlin and Perricelli, 1970; Shi et al., 1985) . The similarity between the yolk sac mesothelial layer ultrastructure and that of an absorptive epithelium has been the only clue to its possible role in absorption (Gonzales-Crussi and Roth, 1976; Jones and Jauniaux, 1995) .
The ECC develops during the fourth week of gestation inside the extra-embryonic mesoderm which forms the outer internal layer of the trophoblast from which it probably derives (Jones and Jauniaux, 1995) . As the amniotic cavity grows, the ECC disappears at the end of the first trimester. Initial studies were carried out to analyse and compare the protein composition of the fluid obtained from the ECC and amniotic cavity in normal pregnancies between 5 and 12 weeks of gestation (Jauniaux et al., 1991 (Jauniaux et al., , 1997 Gulbis et al., 1992; Campbell et al., 1992; Contempre et al., 1993; Nagy et al., 1994; Nonoshita et al., 1994) . Investigations of the various biochemical constituents of these embryonic fluids have demonstrated that the composition of the coelomic fluid (CF) is different from those of amniotic fluid (AF) and maternal serum (MS) at the same point in gestation and that the ECC is the site of important molecular exchanges between the mother and the embryo. There is no anatomical barrier between the mesenchyme of the placental fetal plate and the ECC. Protein electrophoresis has shown that the CF results from an ultrafiltrate of MS with the addition of specific placental and secondary yolk sac bioproducts. This suggests that the ECC is a physiologic liquid extension of the early placenta which may act as a reservoir for nutrients needed by the developing embryo.
The present investigation was performed to evaluate the absorptive function of the human yolk sac membrane by examining the distribution of proteins and enzymes in samples of yolk sac fluid (YSF) and CF and the protein biosynthesis in the main metabolic organs of the embryo and early fetus.
Materials and methods

Patients
Written consent was obtained from 11 woman with uncomplicated early pregnancy (8-12 weeks), interrupted for psychological reasons (Clause C of the 1967 Abortion Act for England and Wales) after receiving complete information on the procedure. The study was approved by The University College London Hospitals Committee on the Ethics of Human Research. Gestational age was determined from the date of the last menstrual period and confirmed by ultrasound and embryological anatomical criteria. Only pregnancies which had been uncomplicated and with a fetal heart rate within normal range were incorporated in the study.
Samples
Embryonic fluids and tissue samples were obtained as previously described (Jauniaux et al., 1991) , during the surgical procedure. Intact yolk sacs were obtained for fluid aspiration which was performed in a Petri dish placed under a dissecting microscope, using a 28 gauge needle. In four cases, intact embryos and placentas were also obtained and samples of the liver and villous tissue were taken. Fluids and tissues were snap-frozen in liquid nitrogen and stored at -70°C.
Protein immunodetection
Following electrophoresis of CF or YSF on agarose gel (Beckman Paragon electrophoresis system, Beckman Instruments Inc, CA, USA) 858 coelomic and yolk sac proteins were transferred onto nitrocellulose sheets, then analysed immunologically with specific rabbit anti-human antibodies (Behring, Marburg, Germany) or anti β-human chorionic gonadotrophin (HCG; Dako, Glostrup, Denmark). Antibody binding was detected by streptavidin-biotin-peroxidase antibody using a secondary biotinylated antibody and 4-chloro-1-naphthol (Amersham, Bucks, UK).
Biochemical procedures
Total protein concentrations were measured in all fluid samples by a pyrogallol red procedure (Sopar Biochem, Brussels, Belgium). Gamma glutamyl transferase (GGT) (E.C. 2.3.2.2) and alkaline phosphatase (ALP) (E.C. 3.1.3.1.) activities were measured at 300C by the IFCCrecommended methods, with commercially available kits (Boehringer Mannheim, Mannheim, Germany). The limit of detection in these assays was 5 IU/l. Intact HCG was measured using a solid-phase two-site immunoradiometric assays (IRMA) kit from BioMerieux (Mercy-l'Etoile, France).
Tissue culture
Placental, liver and yolk sac tissues were each minced and placed separately into Krebs-Ringer bicarbonate buffer containing 1% glucose (KRB-G, Sigma Chimie, Bornem, Belgium) and incubated for 12 h at 37°C with 30 mCi of [ 35 S]-methionine (1000 Ci/mmol, Amersham). Incubation was stopped by separating minced tissue in a 0.1 M Tris, 0.1 M NaCl, 5 mM EDTA, 1%Triton X-100 buffer and each tissue was homogenized in a glass-to-glass homogenizer. The incubation media was kept for bioassay. From each sample, 20 µg of total proteins were subjected to sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) under non-reducing conditions using 12% acrylamide slab gels.
mRNA extraction and RT-PCR amplification
Total RNA was extracted and purified using the Tripure TM Isolation Reagent (Boehringer Mannheim) according to the manufacturers instructions. Total RNA (1 µg) was reverse transcribed under 20 µl using 200 IU of Moloney murine leukaemia virus (MMLV) reverse transcriptase (Life Technologies, Merelbeke, Belgium), 50 mM TrisHCl (pH 8.3), 40 mM KCl, 6 mM MgCl 2 , 10 mM dithiothreitol (DTT), 1 mM dNTP, 10 µg/ml bovine serum albumin (BSA) and 10 pg/ml oligo dT. cDNA (250 ng) (5 µl of RT product) were then amplified using the Taq DNA Polymerase kit (Boehringer Mannheim) and specific primers for β-HCG (Lazar, 1995) , αFP (Niwa, 1996) and β-actin. PCR products of 395, 347 and 237 bp respectively were then separated and visualized on a 2% agarose gel with ethidium bromide staining.
Results
YSF samples contained two main electrophoretic bands with mobilities comparable to albumin and inter albumin-α1-globulin (Figure 2) . Out of the 10 specific proteins tested, eight including albumin, αFP, α1-antitrypsin, α2-macroglobulin, transferrin, complement factors 3 (C3) and 4 (C4) and immunoglobulin (Ig) were revealed by immunoblotting (Figure 3) . In CF, similar results were obtained except for the absence of α2-macroglobulin and the presence of ceruloplasmin and IgA.
The concentration of the different proteins investigated in 11 YSF samples collected from intact yolk sac are shown in Tables I and II . Similar total protein concentrations were found in samples of YSF and CF (2.7 Ϯ 1.3 compared with 3.1 Ϯ 0.4 mg/l; mean Ϯ SD) whereas HCG concentration was 2.8 times lower in YSF than in CF samples (46194 Ϯ 33831 versus 129974 Ϯ 29664 IU/ml; mean Ϯ SD). High concentrations of GGT and variable concentrations of ALP were found in all YSF samples tested, whereas in CF, GGT and ALP activity could not be detected. The AF samples contained low concentrations of total proteins, HCG, GGT and ALP compared with YSF samples.
Four series of matched samples of placental, embryonic liver and secondary yolk sac tissue were available for culture and RNA amplification. After electrophoresis and immunoblotting with specific antibodies, the β subunit of HCG was 859 detected in all placental homogenates and culture media but was not revealed in any of the corresponding yolk sac tissue samples (Figure 4) . Reverse transcription-polymerase chain reaction (RT-PCR) was used to detect βHCG and αFP mRNA in tissues. β-actin mRNA was amplified in each tissue type as a positive control for the RT-PCR. Our results show that all placental samples contain βHCG mRNA, whereas all yolk sac and liver samples contain αFP mRNA ( Figure 5 ). Only one of the liver samples from a pregnancy at 12 weeks showed a weak content of β-HCG mRNA and faint β-HCG staining in culture but not in the homogenate.
Discussion
The results of this study support previous anatomical findings suggesting that the secondary yolk sac has an important absorptive role during human embryonic development. The presence of HCG in the fluid from the lumen of the yolk sac together with the absence of HCG mRNA expression in yolk sac tissue provide the first biological evidence of this absorptive function. In a previous series of experiments, we demonstrated that molecules known not to be synthesized by the embryo before 12 weeks of gestation (e.g. thyroid hormones and IgG) were found in CF samples collected at 5-11 weeks (Contempre et al., 1993; Jauniaux et al., 1995) . In addition, the rapid transfer of insulin between the maternal circulation and the 
860
ECC (Jauniaux et al., 1997) suggested that the latter is an important zone of transfer between the extra-embryonic and embryonic compartments. HCG is a glycoprotein produced almost exclusively during human pregnancy by the placental trophoblast. HCG is composed of two subunits, α and β, which are synthesized separately and are subsequently joined non-covalently (Lapthorn et al., 1994) . Immunohistochemical studies have shown that αHCG mRNA is localized to differentiating cytotrophoblast and syncytial regions, while β-HCG mRNA is localized primarily to the syncytiotrophoblast (Hoshina et al., 1985; Hay, 1988) . After synthesis, HCG is rapidly released from the cells of the trophoblast into both maternal and fetal circulations. Higher intact HCG, free α-HCG and free β-HCG concentrations in CF, in comparison with both AF and MS, can be explained by the close anatomical relationship existing between the ECC and the trophoblast, as both structures are only separated by the loose mesenchymal tissue of the chorionic placental plate Nagy et al., 1994) . The presence of HCG molecules inside the lumen of the yolk sac, therefore, suggests that the yolk sac is an important route of access for high molecular weight proteins to the embryonic circulation.
Similarities in the composition of the fluid obtained from inside the yolk sac and from outside it, i.e. from the ECC, suggest that there is a free transfer between these compartments via the layers of the human yolk sac wall. At 6-12 weeks of gestation, the mean level of total protein is 18 times lower in the CF than in MS and 54 times higher in the CF than in the AF . The concentrations of all molecules tested except urea and αFP are higher in CF than in AF, indicating that the transfer through the amniotic membrane separating these fluid cavities is limited (Gulbis et al., 1992) . αFP is an embryonic specific glycoprotein produced from the second month of pregnancy by the secondary yolk sac, the fetal liver and the gastrointestinal tract. It has been suggested that the yolk sac may perform the functions of the liver in the developing embryo before the fetal liver matures and that it synthesizes a variety of proteins in common with the fetal liver (Gitlin and Perricelli, 1970) . Analyses of molecular variants of αFP have demonstrated that both CF and AF αFP are mainly from yolk sac origin . This bi-directional passage of protein is facilitated by the presence of endodermal cell columns in close contact with the mesothelial layer and the absence of a well-formed basal lamina. Investigation of the secretion of proteins newly synthesized by the rat visceral yolk sac indicates that, although the majority of proteins are secreted into the embryonic compartment, αFP is secreted into both the basolateral and apical chambers, i.e. into the embryonic and extra-embryonic compartments (Thomas et al., 1990) .
GGT is a membrane-bound peptidase enzyme found widely in adult mammalian tissue. The fetal liver and kidney are the main source of GGT in utero and a smaller GGT activity has also been detected in the mucosa of the fetal intestinal and respiratory tracts and amniotic epithelium (Albert et al., 1970; Brock, 1983; Moniz et al., 1984) . GGT activity increases rapidly inside the amniotic cavity after 11 weeks of gestation following the establishment of urinary production by the definitive kidney . The activity of ALP, which is mainly produced by the liver, also increases rapidly in AF after 10 weeks (Jauniaux et al., 1998) . These enzymes are the only molecules that were found in higher concentration in the AF compared with both CF and MS. The absence of enzyme activity in the CF suggests that the placental villi are not a source of these enzymes. It is likely that fetal enzymes remain in its circulation and inside the lumen of the gastrointestinal tract and do not diffuse through the wall of the yolk sac or the amniotic membrane. These findings also suggest that the flux of molecules occurring at the level of yolk sac membrane is mainly unidirectional from the extra-embryonic to the embryonic compartment. α2-macroglobulin, ceruloplasmin and immunoglobulin A are probably synthesized by the yolk sac endodermal layer as they are later in gestation by the fetal liver. Their presence in YSF but not in CF support this hypothesis.
The two main routes of administration considered for fetal 861 gene therapy are intra-amniotic delivery and systemic delivery through the fetal circulation (Douar et al., 1996) . The major limitation of intra-amniotic gene delivery is its dilution by the relatively large volume of amniotic fluid and the absence of specific organ targeting. Embryoscopy permits direct organ biopsy and access to the embryonic circulation (Reece et al., 1993) . With this technique, tissue samples may be removed from the embryo, expanded and transfected in vitro and then reintroduced into its circulation (Reece et al., 1993; Edwards et al., 1995) . The uncertainty regarding the safety of embryoscopy and the availability and use of fetal tissue for this approach remains limiting and controversial. The ultrastructure of the mesothelial and endodermal cells, both of which show a well-developed endocytic apparatus (Jones and Jauniaux, 1995) , has been the only evidence so far available to suggest an absorptive function for the human secondary yolk sac. The presence of a concentration gradient for HCG, which is a high molecular weight protein not synthesized by the yolk sac, between the ECC and the yolk sac lumen supports this concept. This, coupled with evidence that early trophoblast is endocytic in the monkey (Wilson and King, 1985) , which has a comparable embryogenesis to human, raises the possibility that substances or cells injected inside the EEC will be absorbed by the yolk sac mesothelium and subsequently reach the digestive system and/or the circulation of the embryo. Since this approach can be easily performed by operators with experience of amniocentesis and is safer than direct puncture of the embryonic circulation, the present data may help to further develop therapeutic protocols and experiments on nonhuman primates.
